Replimune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
REPL Key Statistics
Stock Snapshot
The current Replimune(REPL) stock price is $11.49, with a market capitalization of 972.09M. The stock trades at a price-to-earnings (P/E) ratio of -3.30.
As of 2026-07-05, Replimune(REPL) stock has fluctuated between $11.09 and $11.95. The current price stands at $11.49, placing the stock +3.6% above today's low and -3.9% off the high.
The Replimune(REPL)'s current trading volume is 2.84M, compared to an average daily volume of 3.76M.
In the last year, Replimune(REPL) shares hit a 52-week high of $13.24 and a 52-week low of $1.50.
In the last year, Replimune(REPL) shares hit a 52-week high of $13.24 and a 52-week low of $1.50.
REPL News
BMO Capital double upgraded Replimune (REPL) to Outperform from Underperform with a price target of $16, up from $1. The FDA’s acceptance of Replimune’s re-file...
Bearish flow noted in Replimune (REPL) Group with 1,899 puts trading, or 1.4x expected. Most active are Aug-26 7 puts and Aug-26 15 calls, with total volume in...
(RTTNews) - Replimune Group Inc. (REPL) revealed Loss for its full year of -$313.940 million The company's bottom line totaled -$313.940 million, or -$3.38 per...
Analyst ratings
50%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.